Golcadomide (GOLCA) ± Rituximab (RTX) Demonstrates Durable Efficacy and Is Well Tolerated in Patients (pts) with Relapsed/Refractory Follicular Lymphoma (R/R FL): Updated Results from the Phase 1/2 CC-99282-NHL-001 Study

  • Chavez, Julio C.; 
  • Perini, Guilherme Fleury; 
  • Nastoupil, Loretta; 
  • Joergensen, Judit Meszaros; 
  • Bories, Pierre; 
  • ... Kim, Won Seog; 
  • 외 13명
Citations

WEB OF SCIENCE

5
제목
Golcadomide (GOLCA) ± Rituximab (RTX) Demonstrates Durable Efficacy and Is Well Tolerated in Patients (pts) with Relapsed/Refractory Follicular Lymphoma (R/R FL): Updated Results from the Phase 1/2 CC-99282-NHL-001 Study
저자
Chavez, Julio C.; Perini, Guilherme Fleury; Nastoupil, Loretta; Joergensen, Judit Meszaros; Bories, Pierre; Fontanet, Bijou; Zinzani, Pier Luigi; Munoz, Javier; Giles, Daniel Morillo; Carpio, Cecilia; Costa, Abel; Kim, Won Seog; Rao, Parth; de Moucheron, Berengere; Gang, Yang; Guarinos, Carla; Sudhindra, Akshay; Pourdehnad, Michael; Michot, Jean-Marie
DOI
10.1182/blood-2024-203131
발행일
2024-11-05
유형
Meeting Abstract
저널명
Blood
권
144
페이지
3018 ~ 3020